The “Big Boys” have rigged the system against you. But in this week’s interview, an expert on our team reveals a way to tip the odds in your favor. Read More
Analyst Articles
Debt-ridden CenturyLink has consistently under-performend the market as well as its peers. Can this battered telecom turn itself around? Read More
Applied Materials is the world's leading supplier of the ultra-sophisticated equipment used in factories that make semiconductors. Will a global glut in chips clobber the stock? Read More
"Sin" stock Philip Morris boasts heavenly dividends. But now, this Big Tobacco stalwart is transitioning to reduced-risk products. Can it succeed? Read More
Comcast is in acquisition mode and rapidly embracing advanced technologies. But as it seeks new avenues for growth, will this multi-media colossus get stretched too thin? Read More
Merck has been a money-making machine for decades, but it faces growing competition and patent expirations. Will this drug giant prevail? Read More
Home Depot is a DJIA component and steady dividend payer. But do economic headwinds and a cooling housing sector pose threats to this retail icon and its payout? Read More
Pfizer is a growth-and-income stock found in many retirement portfolios. But is the competition from biotech "disruptors" getting too hot for this Big Pharma stalwart? Read More
Chevron is poised to gain from rising crude prices, but the energy sector remains volatile. Can this "super major" overcome the industry's uncertainties? Read More
As the largest health insurer in the U.S., UnitedHealth Group is poised to greatly benefit from booming health care expenditures. But do proposed government policy changes threaten the stock? Read More